Crossmark

Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy

Crossref DOI link: https://doi.org/10.1371/journal.pone.0179431

Published Online: 2017-07-05

Update policy: https://doi.org/10.1371/journal.pone.corrections_policy

Authors

Charych, Deborah https://orcid.org/0000-0002-1293-0366
Khalili, Samira

Dixit, Vidula

Kirk, Peter

Chang, Thomas

Langowski, John

Rubas, Werner

Doberstein, Stephen K.

Eldon, Michael

Hoch, Ute

Zalevsky, Jonathan
Funding

Funding for this research was provided by:

Nektar Therapeutics
License Information

Version of Record valid from 2017-07-05

Document is current

Any future updates will be listed below